CanBas Co.,Ltd. (4575)

Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
Period EndTotal current liabilities (Million JPY)YoY (%)
Jun 30, 2025107+16.19%
Jun 30, 202492-40.21%
Jun 30, 2023154-10.90%
Jun 30, 2022173+60.42%
Jun 30, 2021108-61.05%
Jun 30, 2020276+26.16%
Jun 30, 2019219+40.12%
Jun 30, 2018156+136.23%
Jun 30, 201766+73.56%
Jun 30, 201638+15.27%
Jun 30, 201533+26.44%
Jun 30, 201426
AI Chat